TITLE

A combination of antivirals works better than AZT alone

AUTHOR(S)
DeLaney, Martin
PUB. DATE
February 1992
SOURCE
Advocate;2/11/92, Issue 596, p29
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
Comments on developments related to treatment of HIV and AIDS. Media reports focusing on the use of acyclovir in combination with AZT in treatment of people with AIDS; Treatment of chronic herpes-related infections; Plan of Hoffmann-La Roche Inc. to continue its development of the RO-24-7429 anti-HIV drug.
ACCESSION #
9672202

 

Related Articles

  • Resistance to Antiretroviral Drugs: A Threat to the Prevention and Treatment of Pediatric HIV Infection. Krogstad, Paul A. // Journal of Infectious Diseases;5/15/2007, Vol. 195 Issue 10, p1393 

    The article presents a study on resistance to antiretroviral drugs, a threat to the prevention and treatment of pediatric human immunodeficiency virus (HIV) infection. Mother-to-child transmission (MTCT) of HIV were recognized as signatures of HIV infection in infants. Nucleoside analogue...

  • Combining acyclovir and zidovudine for AIDS patients. Donaldson Jr., Robert M.; Berkowitz, Henry D. // Cortlandt Forum;7/25/95, Vol. 8 Issue 7, p92 

    Discusses the use of acyclovir and zidovudine in the treatment of AIDS patients. Reduction in the initial development of opportunistic infections; Prolonged survival in patients with HIV; Side effects of a combination of zidovudine and acyclovir.

  • Combination Therapy for HIV Infection: Getting Closer. Fanci, Anthony S. // Annals of Internal Medicine;1/1/92, Vol. 116 Issue 1, p85 

    Editorial. Comments on issues regarding combination therapy with antiretroviral agents for HIV infection in the U.S. as of January 1992. Observations on research in combination therapy; Views on the use of zidovudine for HIV treatment; Insights on the role of surrogate markers.

  • An antiviral breakthrough. Cohan, Gary R. // Advocate;2/7/95, Issue 674, p43 

    Reports on using AZT with a new drug called 3TC as HIV treatment. Problems with the medications; Benefits and effectiveness of the drug combination.

  • Administration of zidovudine during late pregnancy and delivery to prevent perinatal HIV transmission--Thailand, 1996-1998. Vuthipongse, P.; Bhadrakom, C.; Chaisilwattana, P.; Roongpisuthipong, A.; Chalermchokcharoenkit, A.; Chearskul, S.; Wanprapa, N.; Chokephaibulkit, K.; Tuchinda, M.; Wasi, C.; Chuachoowong, R.; Siriwasin, W.; Chinayon, P.; Asavapiriyanont, S.; Chotpitayasunondh, T.; Waranawat, N.; Sangtaweesin, V.; Horpaopan, S. // JAMA: Journal of the American Medical Association;4/8/98, Vol. 279 Issue 14, p1061 

    Examines the use of zidovudine (ZDV) to prevent perinatal infection with HIV. Testing of drug in the United States and Thailand; Effects of short-term antenatal regimen of ZDV; Methods used in research; Data collected; Estimated HIV transmission risk; Importance of study; Shorter regimen...

  • Primary Lamivudine Resistance in Acute/Early Human Immunodeficiency Virus Infection. Conway, Brian; Montessori, Valentina; Rouleau, Danielle; Montaner, Julio S.G.; O'Shaughnessy, Michael V.; Fransen, Signe; Shillington, Andrew; Weislow, Owen; Mayers, Douglas L. // Clinical Infectious Diseases;4/1/1999, Vol. 28 Issue 4, p910 

    Focuses on a study which described primary resistance to zidovudine in acute and early HIV infection. Patients and methods; Detection of drug resistance; Cases of transmission of resistant virus strains.

  • Early zidovudine treatment for patients with HIV infection.  // American Family Physician;12/1/1995, Vol. 52 Issue 8, p2358 

    Reports on a study on the use of early zidovudine treatment in asymptomatic patients with HIV infections in the United States, as presented in the August 17, 1995 issue of `New England Journal of Medicine.' Comparison between immediate and deferred zidovudine treatment; Effectiveness of...

  • Beginning to Make Progress against HIV. Wilfert, Catherine M. // New England Journal of Medicine;11/28/96, Vol. 335 Issue 22, p1678 

    Opinion. Discusses efforts to reduce perinatal human immunodeficiency virus (HIV) infection. Evidence of the preventive efficacy of zidovudine demonstrated by Sperling et al.; How Sperling's work, called Protocol 076, is being implemented in the United States; Details of three studies...

  • ADAP payments OK'd. Bajko, Matthew S. // Bay Area Reporter;8/29/2002, Vol. 32 Issue 35, p12 

    Reports on the California AIDS Drug Assistance Program. Medications paid for by the government; Benefits from the program.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics